A Study of Non-Scarring Diffuse Alopecia
Abstract
Paucity of reports on non-scarring diffuse alopecia in women from this part of the world led us to take up this study. We examined 200 consecutive cases of non-scarring diffuse alopecia in women who attended the skin OPD of a tertiary level urban hospital to find out the different types of diffuse hair loss, their clinical profile, key diagnostic features and etiological factors associated with them. Chronic telogen effluvium (CTE), female pattern hair loss (FPHL) and telogen effluvium (TE) were found to be the most common types of diffuse hair loss, seen in 71 (35.5%), 70 (35%) and 46 (23%) patients, out of a total of 200. These three (CTE, FPHL and TE) together accounted for 93.5% (187/200) of total cases of non-scarring diffuse alopecia in women. Excessive, alarming, diffuse shedding coming from a normal-looking head with plenty of hair
and without an obvious cause was the hallmark of CTE. FPHL was presented as gradual diffuse hair loss with thinning of central scalp and intact hair line (Ludwig type), widening of central parting line with or without a Christmas tree pattern (Olsen type), or as fronto-temporal/bi-temporal recession with or without loss at vertex (Hamilton type/Male type). An abrupt onset and rapid, diffuse, excessive shedding of normal club hair, usually seen 2–3 months after a triggering event was the typical presentation of TE cases. High fever, postpartum hemorrhage and emotional stress were the common triggers associated with TE. Abnormal thyroid functions (23/200, 11.50%) and anemia (78/200, 39%) were noted in a significant number of cases of diffuse hair loss, making it mandatory to investigate them in all cases of diffuse hair loss.
Keywords
Full Text:
PDFReferences
Shrivastava SB. Diffuse hair loss in adult female:
Approach to diagnosis and management. Indian J
Dermatol Venereol Leprol 2009; 75: 20-28.
Sinclair RD, Banfield CC, Dawber RP. Diffuse hair loss. In:
Sinclair RD, Banfield CC, Dawber RP, editors. Handbook
of Diseases of the Hair and Scalp. UK: Blackwell Science
Ltd 1999; 64-74.
Rustom A, Pasricha JS. Causes of diffuse alopecia in
women. Indian J Dermatol Venereol Leprol 1994; 60:
-71.
Jain VK, Kataria U, Dayal S. Study of diffuse alopecia
in females. Indian J Dermatol Venereol Leprol 2000;
: 65-68.
Whiting DA. Chromic telogen effluvium: Increased
scalp hair shedding in middle-aged women. J Am Acad
Dermatol 1996; 35: 899-906.
Kligman AM. Pathologic dynamics of hair loss. Telogen
effluvium. Arch Dermatol 1961; 83: 175-98.
Thiedke CC. Alopecia in women. Am Fam Physician
; 67: 1007-14.
Shapiro J, Wiseman M, Lui H. Practical management
of hair loss. Can Fam Physician 2000; 46: 1469-77.
Shapiro J, Lui H. Common hair loss disorders. In:
Hordiwnsky MK, Sawaya ME, Scher RK, editors. Atlas
of Hair and Nails. Churchill Livingston; 2000; 91-103.
Dhurat R. Phototrichogram. Indian J Dermatol Venereol
Leprol 2006; 72: 242-44.
Tosti A, Piraccini BM. Telogen effluvium. In: Tosti A,
Piraccini BM, editors. Diagnosis and Treatment of Hair
Disorders. UK: Taylor and Francis 2006; 57-61.
Sperling L. Evaluation of hair loss. Current Problems
in Dermatology 1996; 8: 2-30.
Ross EK, VincenziC, Tosti A. Videodermoscopy in the
evaluation of hair and scalp disorders. J Am Acad
Dermatol 2006; 55: 799-806.
Headington JT. Telogen effluvium: New concepts and
views. Arch Dermatol 1993; 129: 356-63.15. Vexiau P, Chaspoux C et al. Role of androgens in
female-pattern androgenetic alopecia, either alone or
associated with other symptoms of hyperandrogenism.
Archives of Dermatological Research 2000; 292(12):
-604.
Trost LB, Bergfeld WF, Calogeras E. The diagnosis
and treatment of iron deficiency and its potential
relationship to hair loss. J Am Acad Dermatol 2006;
: 824-44.
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Journal of Advanced Research in Medicine (P-ISSN:2394-7047 & E-ISSN:2349-7181)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.